Alkem Laboratories informs about disclosure

07 Jan 2025 Evaluate
Alkem Laboratories has informed that as part of the Company’s operational strategy, the Company shall sell and transfer its undertaking being the manufacturing facility of the Company situated at Plot No. A-17, Phase II, Special Economic Zone, Pithampur, Dhar, Madhya Pradesh, 454775, India (Facility) along with all rights, title and interest in the leasehold land, factory building, assets and liabilities etc. with respect to the said Facility to Rubicon Research Limited (formerly known as Rubicon Research Private Limited) (Rubicon) on a slump sale basis pursuant to the Business Transfer Agreement dated 06 January, 2025 executed between the Company and Rubicon. The details as required under SEBI LODR Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July, 2023 are enclosed herewith as Annexure I.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

4870.45 -9.90 (-0.20%)
15-Apr-2025 13:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1706.00
Dr. Reddys Lab 1147.50
Cipla 1468.10
Lupin 2000.45
Zydus Lifesciences 877.75
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...